Product Highlight: DrugBank Data Dictionary
Read Now!
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Interaction Checker
Check interactions in up to 5 drugs at a time
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
For Drug Discovery
Use Case
Drug Discovery & Repurposing
Visit
DrugBank.com
for detailed drug and target data for your pharmaceutical research.
Products
Data Library
Explore detailed drug information packages to support your research & drug discovery.
Products
Data access in Snowflake
Increase scalability & security by streamlining data sharing & analysis in the cloud.
For Clinical Software
Clinical Intelligence API
Visit
DrugBank.com
to learn about our seamless integration into healthcare software.
Learn more about API Features
Drug Search
Drug-Drug Interaction Checker
Drug Allergy
US Drug Labels
For Academic Research
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Central Nervous System Leukemia (DBCOND0053647)
Identifiers
Synonyms
Central nervous system leukaemia / Central nervous system leukemia
Associated Data
Indicated Drugs and Targets
Not Available
Clinical Trials
Identifier
Title
Drug(s)
Purpose
Phase
Status
NCT02883049
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
Asparaginase Escherichia coli
Beta-D-Glucose
Calcium
Clofarabine
Cortisone
Cyclophosphamide
Cytarabine
Dasatinib
Daunorubicin
Dexamethasone
Doxorubicin
Ethanol
Etoposide
Hydrocortisone
Hydrocortisone succinate
Leucovorin
Levoleucovorin
Mercaptopurine
Methopterin
Methotrexate
Pegaspargase
Prednisone
Sodium succinate
Sulfate ion
Tioguanine
Vincristine
treatment
3
active_not_recruiting
NCT05667402
Clinical Study of TBF Regimen in Allo-HSCT in Patients With CNS Leukemia
No drug interventions
treatment
Not Available
not_yet_recruiting
NCT03959085
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Asparaginase Escherichia coli
Benzalkonium
Calaspargase pegol
Calcium
Carbonate ion
Cyclophosphamide
Cytarabine
Daunorubicin
Dexamethasone
Doxorubicin
Hydrocortisone
Inotuzumab ozogamicin
Leucovorin
Levoleucovorin
Mercaptopurine
Methopterin
Methotrexate
Pegaspargase
Prednisolone
Prednisone
Sulfate ion
Tioguanine
Vincristine
treatment
3
recruiting
NCT01406756
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Asparaginase Escherichia coli
Beta-D-Glucose
Calcium
Clofarabine
Clofarabine
Cortisone
Cyclophosphamide
Cytarabine
Dexamethasone
Doxorubicin
Ethanol
Etoposide
Hydrocortisone
Hydrocortisone succinate
Leucovorin
Levoleucovorin
Mercaptopurine
Methopterin
Methotrexate
Pegaspargase
Prednisone
Sodium succinate
Sulfate ion
Tioguanine
Vincristine
treatment
3
recruiting